PDG38 ASSESSMENT OF GENERIC COMPETITION FOR ORPHAN DRUGS MARKETED IN THE US (1993-2019)
May 1, 2020, 00:00
10.1016/j.jval.2020.04.326
https://www.valueinhealthjournal.com/article/S1098-3015(20)30514-3/fulltext
Title :
PDG38 ASSESSMENT OF GENERIC COMPETITION FOR ORPHAN DRUGS MARKETED IN THE US (1993-2019)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30514-3&doi=10.1016/j.jval.2020.04.326
First page :
Section Title :
Open access? :
No
Section Order :
10192